Safety and Efficacy of Myeloablative Conditioning Autologous Stem Cell Transplantation, Targeted Immunotherapy, and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Children, Adolescents, and Young Adults with Relapsed/Refractory Mature B-Cell Non Hodgkin Lymphoma
Document Type
Abstract
Publication Date
9-2018
DOI
10.1016/j.bbmt.2018.12.832
Journal Title
British Journal of Haematology
Department
Pediatrics
Second Department
Radiology
Third Department
Health Behavior and Community Health
Recommended Citation
Gardenswartz, A., Mehta, B., El-Mallawany, N. K., van der Ven, C., Hochberg, J., Flower, A., Morris, E., Harrison, L., Basso, J., Gerard, P., Ayello, J., Baxter-Lowe, L., & Cairo, M. S. (2018). Safety and Efficacy of Myeloablative Conditioning Autologous Stem Cell Transplantation, Targeted Immunotherapy, and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Children, Adolescents, and Young Adults with Relapsed/Refractory Mature B-Cell Non Hodgkin Lymphoma. British Journal of Haematology, 182 (Suppl. 1), 23. https://doi.org/10.1016/j.bbmt.2018.12.832